MDS Inc.

MDS

[ equipment for the production of radioisotopes, namely, gas target systems, having a target chamber, a storage vessel, and an ion exchange column, which allow the bombardment of a target material with proton beams to produce radioisotopes, solid target systems having a hot cell, transfer line, and target station, which allow bombardment of target material with proton beams to produce radioisotopes, and cyclotrons; radiation processing equipment, namely, cyclotron systems utilizing isotope processing technology whereby target materials are bombarded with proton to produce cyclotron products; industrial irradiation equipment, namely production irradiators, associated control consoles, conveyor systems used to move product-filled totes in and out of the irradiation chambers, source hoists, load and unload stations, monitors and carriers, pallets and totes, containers for radiation emitting energy sources, self-containing irradiators for irradiation of sample materials, and dosimeters and dosimeter systems for measuring radiation dose; radiation emitting energy sources, namely radioisotopes for non-medical purposes; computer hardware, software and monitors all used to monitor irradiators control functions and attached peripherals; and computer software and accompanying instruction manuals sold as a unit used for patient specimen analysis, recording and reporting ];[ radioisotopes for medical diagnostic use, and for medical therapeutic use, radiopharmaceuticals for medical diagnostic use, and for medical therapeutic use ];[ installation, maintenance and repair of medical laboratory equipment, and of computers and computer systems used as part of medical laboratory equipment for patient specimen handling and analysis ];[ wholesale distributorships featuring medical laboratory equipment, computer hardware and monitors and attached peripherals, and computer programs, all used for patient specimen handling and analysis ];[ radioisotopes for scientific or research use ];[ medical irradiation equipment, namely, blood irradiators for treatment of blood and blood components, and radioisotopes for use outside the human body for medical diagnostic and medical therapeutic uses; and laboratory equipment, namely electrical automated sorting machines used to sort medical laboratory specimens ];[ installation, maintenance and updating of computer programs used for patient specimen handling and analysis; ] pharmaceutical services, namely, professional consultancy and consultation services in the fields of biotechnology, biochemistry, pharmacology [ and medicine ] ; research services in the fields of biotechnology, biochemistry, pharmacology [ and medicine ];

MDS

equipment for the production of radioisotopes, namely, gas target systems having a target chamber, a storage vessel, and an ion exchange column, which allow the bombardment of a target material with proton beams to produce radioisotopes, solid target systems having a hot cell, transfer line, and target station, which allow the bombardment of target material with proton beams to produce radioisotopes, and cyclotrons; radiation processing equipment, namely, cyclotron systems utilizing isotope processing technology whereby target materials are bombarded with proton beams to produce cyclotron products; industrial irradiation equipment, namely, production irradiators, associated control consoles, conveyor systems used to move product-filled totes in and out of the irradiation chambers, source hoists, load and unload stations, monitors and carriers, pallets and totes, containers for radiation emitting energy sources, self-containing irradiators for irradiation of sample materials, and dosimeters and dosimeter systems for measuring radiation dose; radiation emitting energy sources, namely radioisotopes for non-medical purposes; computer hardware, software and monitors all used to monitor irradiator control functions and attached peripherals; and computer software and accompanying instruction manuals sold as a unit used for patient specimen analysis, recording and reporting;radioisotopes for medical diagnostic use, and for medical therapeutic use, radiopharmaceuticals for medical diagnostic use, and for medical therapeutic use;installation, maintenance and repair of medical laboratory equipment, and of computers and computer systems used as part of medical laboratory equipment for patient specimen handling and analysis;wholesale distributorships featuring medical laboratory equipment, computer hardware and monitors and attached peripherals, and computer programs, all used for patient specimen handling and analysis;radioisotopes for scientific or research use;medical irradiation equipment, namely, blood irradiators for treatment of blood and blood components, and radioisotopes for use outside the human body for medical diagnostic and medical therapeutic uses; and laboratory equipment, namely electrical automated sorting machines used to sort medical laboratory specimens;installation, maintenance and updating of computer programs used for patient specimen handling and analysis; pharmaceutical services, namely, professional consultancy and consultation services in the fields of biotechnology, biochemistry, pharmacology and medicine; research services in the fields of biotechnology, biochemistry, pharmacology and medicine;

MDS PROTEOMICS

computer programs for assays for the diagnosis of diseases, computer programs for chemicals markers for disease states, computer programs for performing diagnostics for diseases, computer programs for determining targets for drugs, computer programs for determining protein and peptide sequences; and scientific instruments, namely mass spectrometers, automated sample preparers for mass spectrometers, and parts and accessories for the foregoing, all for developing assays for the diagnosis of diseases, and for developing chemical markers for disease states, and for performing diagnostics for diseases, and for determining targets for drugs, and for determining protein and peptide sequences;PROTEOMICS;scientific research, namely developing assays for the diagnosis of diseases; developing chemical markers for disease states; determining targets for drugs; determining protein and peptide sequences; and developing methodologies relating to the foregoing; and performing the foregoing services;

MDS PROTEOMICS

Computer programs relating to assays for the diagnosis of diseases, namely computer programs which utilize data from a patient specimen assay and compare it to values which are considered to be normal, and computer programs for automatically performing all or a portion of the disease diagnostic process; computer programs relating to chemical markers for disease states, namely computer programs for monitoring several disease states using two or more chemical markers in each assay and for comparing the concentration of each marker with a database; computer programs for performing diagnostics for diseases by analyzing the results of an assay and providing an indication of possible disease states; computer programs relating to determining targets for drugs, namely computer programs for inspecting and analyzing databases of biological processes and predicting potential drug targets; computer programs relating to determining protein and peptide sequences, namely computer programs for accepting analysis results and for determining therefrom which biological substances are present and the structure of such biological substances;Color is not claimed as a feature of the mark.;PROTEOMICS;Medical research, namely developing assays for the diagnosis of diseases;

MDSP

Computer programs relating to assays for the diagnosis of diseases, namely computer programs which utilize data from a patient specimen assay and compare it to values which are considered to be normal, and computer programs for automatically performing all or a portion of the disease diagnostic process; computer programs relating to chemical markers for disease states, namely computer programs for monitoring several disease states using two or more chemical markers in each assay and for comparing the concentration of each marker with a database; computer programs for performing diagnostics for diseases by analyzing the results of an assay and providing an indication of possible disease states; computer programs relating to determining targets for drugs, namely computer programs for inspecting and analyzing databases of biological processes and predicting potential drug targets; computer programs relating to determining protein and peptide sequences, namely computer programs for accepting analysis results and for determining therefrom which biological substances are present and the structure of such biological substances; scientific instruments for developing assays for the diagnosis of diseases, and for developing chemical markers for disease states, and for performing diagnostics for diseases, and for determining targets for drugs, and for determining protein and peptide sequences, namely mass spectrometers, sample separation apparatus, sample enrichment apparatus, sample preparation apparatus, optical detectors, and micro-fluidic sample processing apparatus;Medical research, namely developing assays for the diagnosis of diseases; developing chemical markers which indicate the presence of disease states; performing diagnostics for diseases, namely analyzing and reporting on patient specimens; determining biological targets for drugs, namely determining biological processes which are susceptible to being affected by drugs, in order that the drugs may alleviate disease states and conditions in humans and animals; determining protein and peptide sequences for the purposes of identifying protein or peptide drug targets, and for developing sequencing databases; developing methodologies relating to the foregoing services, namely developing bioanalytical methods to increase the throughtput of the identification and characterization of biological substances such as proteins used as biomarkers for a diagnosis or as drug targets, and developing biochemistry processes and instrumentation for said foregoing services, and developing simplified methods of performing said foregoing services and developing methods to reduce the sample sizes needed, and to increase the reliability of assays; and leasing of medical equipment, namely mass spectrometers, electrophoresis analyzers, separation apparatus, namely liquid chromatographs and capillary electrophoresis apparatus, optical detection systems, namely ultraviolet, fluorescence and chemiluminescent detectors, microfluid apparatus and sample preparation apparatus;

METABOLOME

Computer programs for performing and reporting on assays for the diagnosis of diseases; computer programs that report on chemical markers for diseases states; computer programs for performing diagnostics for diseases; computer programs for determining targets for drugs; computer programs for measuring metabolite levels; scientific instruments, namely, mass spectrometers and inlet ionizers therefor, for developing chemical markers for disease states; scientific instruments, namely, mass spectrometers and inlet ionizers therefor, for performing diagnostics for diseases; scientific instruments, namely mass spectrometers and inlet ionizers therefor, for determining targets for drugs; scientific instruments, namely mass spectrometers and inlet ionizers therefor, for measuring metabolite level;Developing assays for others, namely, providing analysis for the diagnosis of diseases; developing for others chemical markers for disease states; performing for others diagnostics for diseases; determining for others targets for drugs; biological product analysis services for others; measuring for others metabolite levels; consulting services in the nature of supplying know-how and developing for others new diagnostic tools, all relating to small molecule metabolism; and developing for others methodologies relating to the foregoing;

METABOLOMICS

Computer programs for performing and reporting on assays for the diagnosis of diseases; computer programs that report on chemical markers for diseases states; computer programs for performing diagnostics for diseases; computer programs for determining targets for drugs; computer programs for measuring metabolite levels; scientific instruments, namely, mass spectrometers and inlet ionizers therefor, for developing chemical markers for disease states; scientific instruments, namely, mass spectrometers and inlet ionizers therefor, for performing diagnostics for diseases; scientific instruments, namely mass spectrometers and inlet ionizers therefor, for determining targets for drugs; scientific instruments, namely mass spectrometers and inlet ionizers therefor, for measuring metabolite level;Developing assays for others, namely, providing analysis for the diagnosis of diseases; developing for others chemical markers for disease states; performing for others diagnostics for diseases; determining for others targets for drugs; biological product analysis services for others; measuring for others metabolite levels; consulting services in the nature of supplying know-how and developing for others new diagnostic tools, all relating to small molecule metabolism; and developing for others methodologies relating to the foregoing;

PROTEOMICS

computer programs relating to assays for the diagnosis of diseases, computer programs relating to chemical markers for disease states, computer programs relating to performing diagnostics for diseases, computer programs relating to determining targets for drugs, computer programs relating to determining protein and peptide sequences, scientific instruments for developing assays for the diagnosis of diseases, scientific instruments for developing chemical markers for disease states, scientific instruments for performing diagnostics for diseases, scientific instruments for determining targets for drugs, and scientific instruments for determining protein and peptide sequences;developing assays for the diagnosis of diseases; developing chemical markers for disease states;performing diagnostics for diseases; determining targets for drugs; determining protein and peptide sequences; developing methodologies relating to the foregoing, and the operation of a business dealing in scientific instrumentation for performing the foregoing services;

SARESA

Pharmaceutical preparations for the treatment of radioimmune diseases, namely radioimmunetherapeutics; pharmaceutical preparations in the nature of drug antibody and toxin-antibody conjugates for the purpose of removing and fighting toxins in the body; pharmaceutical preparations in the nature of targeted therapeutics for the diagnosis, therapy and/or prevention of human conditions or disease, namely for use in the treatment of cancer, specifically blood borne cancers and solid tumors;pharmaceutical preparations in the nature of drug delivery agents consisting compounds that facilitate delivery of a wide range of pharmaceuticals comprised of proteins,peptides, peptidomimetics, lipids, carbohydrates, nucleic acids, aptamers, and/or synthetic organic molecules, that selectively bind to any human or bacterial cell, any cell type, any fungus, any virus, any human pathogen, or any component of the above,including fragments and semi-synthetic derivatives;Pharmaceutical drug development services; scientific research in the field of pharmaceuticals; medical and scientific research, namely conducting clinical trials of pharmaceuticals;

SCIENCE ADVANCING HEALTH

installation, maintenance and repair of medical laboratory equipment, and of computers and computer systems used as part of medical laboratory equipment for patient specimen handling and analysis;wholesale distributorships featuring medical laboratory equipment, computer hardware and monitors and attached peripherals, and computer programs, all used for patient specimen handling and analysis;installation, maintenance and repair of computer programs used for patient specimen handling and analysis;

SPEEDLINE

sale and distribution of satellite delivered services and related products; telecommunication services;SPEED LINE;

SPEEDLINE

wireless point of sale terminals;SPEED LINE;

TARGETED MEDICINES BY DESIGN

Pharmaceutical preparations for the treatment of radioimmune diseases, namely radloimmunotherapeutics; pharmaceutical preparations in the nature of drug antibody and toxin-antibody conjugates for the purpose of removing and fighting toxins in the body; pharmaceutical preparations in the nature of targeted therapeutics for the diagnosis, therapy and/or prevention of human conditions or disease, namely for use in the treatment of cancer, specifically blood borne cancers and solid tumors; pharmaceutical preparations in the nature of drug delivery agents consisting compounds that facilitate delivery of a wide range of pharmaceuticals comprised of proteins, peptides, peptidomimetics, lipids, carbohydrates, nucleic acids, aptamers, and/or synthetic organic molecules, that selectively bind to any human or bacterial cell, any cell type, any fungus, any virus, any human pathogen, or any component of the above, including fragments and semi-synthetic derivatives;Pharmaceutical drug development services; scientific research in the field of pharmaceuticals; medical and scientific research, namely conducting clinical trials of pharmaceuticals;

TUBE MAGAZINE

television listings;